《近期临床试验评论》(Reviews On Recent Clinical Trials)是一本以PHARMACOLOGY & PHARMACY综合研究为特色的国际期刊。该刊由Bentham出版商该刊已被国际重要权威数据库SCIE收录。期刊聚焦PHARMACOLOGY & PHARMACY领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信息窗口与平...
In the West,hundreds of randomized controlled trials(RCTs)have been performed testing acupuncture.They include two types:those that compare acupuncture to other therapies,usual care or no treatment(pragmatic trials),and those that have placebo controls(efficacy trials).Acupuncture has generally performed...
There were 481 clinical trials on rare diseases in total, covering more than 10 rare diseases with high incidence. Clinical trial applications on rare diseases for a total of 481 were submitted and with an average annual growth rate of 28.2% from 2013 to 2022. The number of clinical trial ...
Accessed March 16, 2022. https://clinicaltrials.gov/ct2/show/NCT03158688 Multinational clinical study comparing isatuximab, carfilzomib and dexamethasone to carfilzomib and dexamethasone in relapse and/or refractory multiple myeloma patients (IKEMA). ClinicalTrials.gov identifier: NCT03275285. Accessed ...
2023 The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lo...
Recent Advances in Approved, Withdrawn, Experimental and Investigational Drugs in Clinical Trials for Alzheimer's disease 来自 Semantic Scholar 喜欢 0 阅读量: 3 作者: R Deshpande 摘要: Alzheimer's disease (AD) is an irreversible, chronic degenerative disease that slowly destroys memory and thinking ...
[145]. However, further development was discontinued after a phase 2 trial in humans without explanation. BAY 2395840 was developed as an oral treatment for diabetic neuropathic pain [146]. In April 2022, the manufacturer announced the termination of development on clinicaltrials.gov, as no ...
2022; 82: 5523. Nanjing Leads Biolabs Co. L. evaluation of LBL-019 monotherapy or combined with Anti-PD-1 antibody in the treatment of Advanced Malignant tumors. 2024. https://clinicaltrials.gov/study/NCT05223231 SIM0235. aTNFR2 monoclonal antibody independently developed by Simcere received ...
Exubera®. Moreover, many other products of this type have been undergoing clinical trials (Karimi et al.2022). Table1. shows a number of biopharmaceutical products with FDA approval and biopharmaceuticals in clinical trials since 2018. However, Resusix® clinical trial was terminated (Enteg...
Circulating tumor dna in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences. Clin Cancer Res. 2022;28:507–17. https://doi.org/10.1158/1078-0432.CCR-21-2404/674041/AM/CIRCULATING-TUMOR-DNA-IN...